BACKGROUND: Moderate consumption of alcohol, particularly red wine, has been shown to decrease cardiac risk. We used a hypercholesterolemic swine model of chronic ischemia to examine the effects of 2 alcoholic beverages on the heart. METHODS AND RESULTS: Yorkshire swine fed a high-cholesterol diet underwent left circumflex ameroid constrictor placement to induce chronic ischemia at 8 weeks of age. One group (HCC, n=9) continued on the diet alone, the second (HCW, n=8) was supplemented with red wine (pinot noir, 12.5% alcohol, 375 mL daily), and the third (HCV, n=9) was supplemented with vodka (40% alcohol, 112 mL daily). After 7 weeks, cardiac function was measured, and ischemic myocardium was harvested for analysis of perfusion, myocardial fibrosis, vessel function, protein expression, oxidative stress, and capillary density. Platelet function was measured by aggregometry. Perfusion to the ischemic territory as measured by microsphere injection was significantly increased in both HCW and HCV compared with HCC at rest, but in only the HCW group under ventricular pacing. Microvessel relaxation response to adenosine 5'-diphosphate was improved in the HCW group alone as was regional contractility in the ischemic territory, although myocardial fibrosis was decreased in both HCW and HCV. Expression of proangiogenic proteins phospho-endothelial nitric oxide synthase and vascular endothelial growth factor was increased in both HCW and HCV, whereas phospho-mammalian target of rapamycin was increased only in the HCV group. Expression of Sirt-1 and downstream antioxidant phospho-FoxO1 was increased only in the HCW group. Protein oxidative stress was decreased in the HCW group alone, whereas capillary density was increased only in the HCV group. There was no significant difference in platelet function between groups. CONCLUSION: Moderate consumption of red wine and vodka may reduce cardiovascular risk by improving collateral-dependent perfusion through different mechanisms. Red wine may offer increased cardioprotection related to its antioxidant properties.
BACKGROUND: Moderate consumption of alcohol, particularly red wine, has been shown to decrease cardiac risk. We used a hypercholesterolemicswine model of chronic ischemia to examine the effects of 2 alcoholic beverages on the heart. METHODS AND RESULTS: Yorkshire swine fed a high-cholesterol diet underwent left circumflex ameroid constrictor placement to induce chronic ischemia at 8 weeks of age. One group (HCC, n=9) continued on the diet alone, the second (HCW, n=8) was supplemented with red wine (pinot noir, 12.5% alcohol, 375 mL daily), and the third (HCV, n=9) was supplemented with vodka (40% alcohol, 112 mL daily). After 7 weeks, cardiac function was measured, and ischemic myocardium was harvested for analysis of perfusion, myocardial fibrosis, vessel function, protein expression, oxidative stress, and capillary density. Platelet function was measured by aggregometry. Perfusion to the ischemic territory as measured by microsphere injection was significantly increased in both HCW and HCV compared with HCC at rest, but in only the HCW group under ventricular pacing. Microvessel relaxation response to adenosine 5'-diphosphate was improved in the HCW group alone as was regional contractility in the ischemic territory, although myocardial fibrosis was decreased in both HCW and HCV. Expression of proangiogenic proteins phospho-endothelial nitric oxide synthase and vascular endothelial growth factor was increased in both HCW and HCV, whereas phospho-mammalian target of rapamycin was increased only in the HCV group. Expression of Sirt-1 and downstream antioxidant phospho-FoxO1 was increased only in the HCW group. Protein oxidative stress was decreased in the HCW group alone, whereas capillary density was increased only in the HCV group. There was no significant difference in platelet function between groups. CONCLUSION: Moderate consumption of red wine and vodka may reduce cardiovascular risk by improving collateral-dependent perfusion through different mechanisms. Red wine may offer increased cardioprotection related to its antioxidant properties.
Authors: Simona Costanzo; Augusto Di Castelnuovo; Maria Benedetta Donati; Licia Iacoviello; Giovanni de Gaetano Journal: J Am Coll Cardiol Date: 2010-03-30 Impact factor: 24.094
Authors: Torstein Jensen; Lars J Retterstøl; Per M Sandset; Hans C Godal; Ole H Skjønsberg Journal: Blood Coagul Fibrinolysis Date: 2006-09 Impact factor: 1.276
Authors: Subhendu Mukherjee; Istvan Lekli; Narasimman Gurusamy; Alberto A A Bertelli; Dipak K Das Journal: Free Radic Biol Med Date: 2008-11-24 Impact factor: 7.376
Authors: Paul Sorajja; Bernard J Gersh; Roxana Mehran; Alexandra J Lansky; Mitchell W Krucoff; John Webb; David A Cox; Bruce R Brodie; Gregg W Stone Journal: Am Heart J Date: 2007-08 Impact factor: 4.749
Authors: Neel R Sodha; Richard T Clements; Jun Feng; Yuhong Liu; Cesario Bianchi; Eszter M Horvath; Csaba Szabo; Frank W Sellke Journal: Eur J Cardiothorac Surg Date: 2008-03-07 Impact factor: 4.191
Authors: Antonio D Lassaletta; Louis M Chu; Nassrene Y Elmadhun; Michael P Robich; Zachary G Hoffman; David J Kim; Frank W Sellke Journal: Eur J Cardiothorac Surg Date: 2012-09-18 Impact factor: 4.191
Authors: Antonio D Lassaletta; Nassrene Y Elmadhun; Yuhong Liu; Jun Feng; Thomas A Burgess; Nicholas W Karlson; Roger J Laham; Frank W Sellke Journal: Circulation Date: 2013-09-10 Impact factor: 29.690
Authors: Kimberly D McCarter; Chun Li; Zheng Jiang; Wei Lu; Hillary A Smith; Guodong Xu; William G Mayhan; Hong Sun Journal: Sci Rep Date: 2017-10-02 Impact factor: 4.379